水痘疫苗的经济学评估：一项系统评价的结果
Economic evaluation of Varicella vaccination: results of a systematic review.
作者信息
Unim Brigid, Saulle Rosella, Boccalini Sara, Taddei Cristina, Ceccherini Vega, Boccia Antonio, Bonanni Paolo, La Torre Giuseppe
机构信息
Department of Public Health and Infectious Diseases; Sapienza University of Rome; Rome, Italy.
出版信息
Hum Vaccin Immunother. 2013 Sep;9(9):1932-42. doi: 10.4161/hv.25228. Epub 2013 Jul 3.
Abstract
INTRODUCTION
The aim of the present study is to review the economic burden of varicella disease and the benefit of universal varicella vaccination in different settings pending its implementation in all Italian regions.
MATERIALS AND METHODS
Research was conducted using PubMed, Scopus and ISI databases. Score quality and data extraction were performed for all included studies.
RESULTS
Twenty-three articles met the criteria: 15 cost-effectiveness, 8 cost-benefit and one cost-utility analysis. Varicella vaccination could save the society from €637,762 (infant strategy) to 53 million annually (combined infant and adolescent strategy). The median and the mean quality scores resulted in 91.8% and 85.4% respectively; 11 studies were considered of high quality and 12 of low quality.
DISCUSSION
The studies are favorable to the introduction of universal varicella vaccination in Italy, being cost saving and having a positive impact on morbidity. The quality score of the studies varied greatly: recent analyses were of comparable quality to older studies.
摘要
引言
本研究旨在回顾水痘疾病的经济负担以及在意大利所有地区实施全民水痘疫苗接种之前，在不同环境下进行全民水痘疫苗接种的益处。
材料与方法
使用PubMed、Scopus和ISI数据库进行研究。对所有纳入研究进行评分质量评估和数据提取。
结果
23篇文章符合标准：15篇成本效益分析、8篇成本效益分析和1篇成本效用分析。水痘疫苗接种每年可为社会节省637,762欧元（婴儿策略）至5300万欧元（婴儿和青少年联合策略）。中位数和平均质量得分分别为91.8%和85.4%；11项研究被认为质量高，12项质量低。
讨论
这些研究支持在意大利引入全民水痘疫苗接种，因为这既能节省成本，又能对发病率产生积极影响。研究的质量得分差异很大：近期分析的质量与早期研究相当。
相似文献
1
Economic evaluation of Varicella vaccination: results of a systematic review.水痘疫苗的经济学评估：一项系统评价的结果
Hum Vaccin Immunother. 2013 Sep;9(9):1932-42. doi: 10.4161/hv.25228. Epub 2013 Jul 3.
2
Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.对评估高收入国家常规水痘和带状疱疹疫苗接种经济价值模型的系统评价。
BMC Public Health. 2015 Jun 5;15:533. doi: 10.1186/s12889-015-1861-8.
3
Investigation and analysis of influencing factors on the economic burden of varicella disease in Qingyang, China, 2024.2024年中国庆阳水痘疾病经济负担影响因素的调查与分析
Hum Vaccin Immunother. 2025 Dec;21(1):2521188. doi: 10.1080/21645515.2025.2521188. Epub 2025 Jul 1.
4
Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus.打破循环：针对水痘-带状疱疹病毒的终生疫苗接种策略考量
Expert Rev Vaccines. 2025 Dec;24(1):556-569. doi: 10.1080/14760584.2025.2514527. Epub 2025 Jun 19.
5
A systematic review of the cost effectiveness of herpes zoster vaccination.带状疱疹疫苗成本效益的系统评价。
Pharmacoeconomics. 2013 Feb;31(2):125-36. doi: 10.1007/s40273-012-0020-7.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review.建模一种具有成本效益的疫苗接种策略，以预防水痘和带状疱疹感染：系统评价。
Vaccine. 2021 Mar 1;39(9):1370-1382. doi: 10.1016/j.vaccine.2021.01.061. Epub 2021 Feb 4.
8
Changes in Epidemiological Characteristics of Varicella and Breakthrough Cases in Ningbo, China, From 2010 to 2023: Surveillance Study.2010年至2023年中国宁波水痘及突破性病例的流行病学特征变化：监测研究
JMIR Public Health Surveill. 2025 Jun 18;11:e71691. doi: 10.2196/71691.
9
Parental perceptions of chickenpox and the varicella vaccine: A qualitative systematic review.家长对水痘和水痘疫苗的认知：定性系统评价。
Vaccine. 2024 Jan 12;42(2):75-83. doi: 10.1016/j.vaccine.2023.12.045. Epub 2023 Dec 20.
10
Vaccines for measles, mumps, rubella, and varicella in children.儿童麻疹、腮腺炎、风疹和水痘疫苗。
Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD004407. doi: 10.1002/14651858.CD004407.pub5.
引用本文的文献
1
Systematic review of economic evaluations of varicella vaccination programmes.水痘疫苗接种项目的经济评价系统综述。
PLoS One. 2023 Mar 27;18(3):e0282327. doi: 10.1371/journal.pone.0282327. eCollection 2023.
2
Assessing the use of antibiotics in pediatric patients hospitalized for varicella.评估住院治疗水痘的儿科患者中抗生素的使用情况。
Ital J Pediatr. 2022 Dec 12;48(1):196. doi: 10.1186/s13052-022-01393-5.
3
Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study.2011 年至 2021 年中国两剂次水痘疫苗的长期疫苗效力：一项回顾性观察研究。
Front Public Health. 2022 Nov 8;10:1039537. doi: 10.3389/fpubh.2022.1039537. eCollection 2022.
4
Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States.美国水痘普遍疫苗接种对水痘管理中抗生素和抗病毒药物使用和成本的影响。
PLoS One. 2022 Jun 10;17(6):e0269916. doi: 10.1371/journal.pone.0269916. eCollection 2022.
5
Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy.儿童临床和流行病学水痘负担随时间有变化吗？意大利2010年至2017年住院治疗、合并症及费用概述。
Vaccines (Basel). 2021 Dec 15;9(12):1485. doi: 10.3390/vaccines9121485.
6
Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks.水痘暴发期间突破性水痘的临床特征及相关危险因素。
Hum Vaccin Immunother. 2020 Aug 2;16(8):1851-1856. doi: 10.1080/21645515.2019.1704574. Epub 2020 Mar 2.
7
Budget impact analysis of multiple varicella vaccination strategies: a Mexico perspective.多种水痘疫苗接种策略的预算影响分析：墨西哥视角
Hum Vaccin Immunother. 2020 Apr 2;16(4):886-894. doi: 10.1080/21645515.2019.1672491. Epub 2019 Dec 18.
8
Global impact of varicella vaccination programs.全球水痘疫苗接种计划的影响。
Hum Vaccin Immunother. 2019;15(3):645-657. doi: 10.1080/21645515.2018.1546525. Epub 2018 Dec 10.
9
Varicella vaccination - the global experience.水痘疫苗——全球经验
Expert Rev Vaccines. 2017 Aug;16(8):833-843. doi: 10.1080/14760584.2017.1343669. Epub 2017 Jul 13.
10
Economic evaluations of vaccines in Canada: a scoping review.加拿大疫苗的经济评估：一项范围综述。
Cost Eff Resour Alloc. 2017 May 5;15:7. doi: 10.1186/s12962-017-0069-4. eCollection 2017.
本文引用的文献
1
Varicella vaccination in Japan: necessity of implementing a routine vaccination program.日本水痘疫苗接种：实施常规疫苗接种计划的必要性。
J Infect Chemother. 2013 Apr;19(2):188-95. doi: 10.1007/s10156-013-0577-x. Epub 2013 Mar 13.
2
Evaluation of Australia's varicella vaccination program for children and adolescents.评估澳大利亚儿童和青少年水痘疫苗接种计划。
Vaccine. 2013 Feb 27;31(10):1413-9. doi: 10.1016/j.vaccine.2012.12.052. Epub 2013 Jan 2.
3
National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2011.2011 年美国 19-35 月龄儿童全国、州和地区疫苗接种覆盖率。
MMWR Morb Mortal Wkly Rep. 2012 Sep 7;61:689-96.
4
Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy.意大利现行的肺炎球菌、脑膜炎球菌 C 型、水痘和轮状病毒疫苗免疫接种政策。
Health Policy. 2011 Dec;103(2-3):176-83. doi: 10.1016/j.healthpol.2011.10.002. Epub 2011 Oct 26.
5
Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.政策声明——水痘预防：更新儿童使用四价和单价水痘疫苗的建议。
Pediatrics. 2011 Sep;128(3):630-2. doi: 10.1542/peds.2011-1968. Epub 2011 Aug 28.
6
Effectiveness of 2 doses of varicella vaccine in children.两剂水痘疫苗在儿童中的有效性。
J Infect Dis. 2011 Feb 1;203(3):312-5. doi: 10.1093/infdis/jiq052.
7
Impact of 2-dose vaccination on varicella epidemiology: Connecticut--2005-2008.两剂疫苗接种对水痘流行病学的影响：康涅狄格州，2005-2008 年。
J Infect Dis. 2011 Feb 15;203(4):509-12. doi: 10.1093/infdis/jiq081. Epub 2011 Jan 3.
8
Economic evaluation of varicella vaccination in Swiss children and adolescents.瑞士儿童和青少年水痘疫苗接种的经济学评估。
Hum Vaccin. 2009 Dec;5(12):847-57. doi: 10.4161/hv.9898. Epub 2009 Dec 23.
9
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.《系统评价与Meta分析优先报告条目声明》：针对评估卫生保健干预措施的研究的报告规范解释与阐述
Ann Intern Med. 2009 Aug 18;151(4):W65-94. doi: 10.7326/0003-4819-151-4-200908180-00136. Epub 2009 Jul 20.
10
Varicella vaccination in Europe - taking the practical approach.欧洲的水痘疫苗接种——采取实际方法
BMC Med. 2009 May 28;7:26. doi: 10.1186/1741-7015-7-26.
Zotero 插件